Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Depreciation & Amortization (CF) (2021 - 2025)

P3 Health Partners (PIII) has disclosed Depreciation & Amortization (CF) for 5 consecutive years, with $21.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) fell 2.95% year-over-year to $21.0 million, compared with a TTM value of $84.3 million through Sep 2025, down 2.66%, and an annual FY2024 reading of $86.1 million, down 0.71% over the prior year.
  • Depreciation & Amortization (CF) was $21.0 million for Q3 2025 at P3 Health Partners, roughly flat from $21.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $22.0 million in Q4 2022 and bottomed at $332548.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $17.8 million, with a median of $21.5 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) surged 6441.01% in 2022, then dropped 2.95% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $356204.0 in 2021, then soared by 6076.8% to $22.0 million in 2022, then fell by 1.28% to $21.7 million in 2023, then decreased by 2.61% to $21.2 million in 2024, then dropped by 0.57% to $21.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for PIII at $21.0 million in Q3 2025, $21.1 million in Q2 2025, and $21.1 million in Q1 2025.